Nakagawa Sae, Shakuo Tomoharu, Matsudo Sakurako, Soda Hiroaki, Shida Kenji
Department of Anesthesiology, Showa University Northern Yokohama Hospital, 35-1, Chigasaki-Chuo, Tsuzuki-Ku, Yokohama-Shi, Kanagawa-Ken 224-8503, Japan.
Case Rep Anesthesiol. 2023 May 15;2023:2352693. doi: 10.1155/2023/2352693. eCollection 2023.
Critical upper airway obstruction, hematoma formation, and recurrent laryngeal nerve palsy have been reported as postoperative complications of thyroid surgery. Although remimazolam may reduce the risk of these complications, the efficacy of flumazenil with remimazolam has not been reported. We present the successful anesthesia management of thyroid surgery using remimazolam and flumazenil. . A 72-year-old woman was diagnosed with a goiter and scheduled for a partial thyroidectomy under general anesthesia. We used remimazolam for induction and maintenance using a neural integrity monitor, electromyogram, and endotracheal tube under the bispectral index monitor. At the end of the surgery, spontaneous respiration was confirmed after the intravenous administration of sugammadex, and the patient was extubated under mild sedation. In the operating room, we administered flumazenil intravenously to confirm recurrent laryngeal nerve palsy and active postoperative hemorrhage. The patient was confirmed to have no recurrent laryngeal nerve palsy under full wakefulness but developed active postoperative hemorrhage with normal blood pressure. The patient required reoperation and was reintubated under intravenous administration of propofol. The anesthesia was maintained using 5% of desflurane, and the patient was extubated without any postoperative problems. The anesthesia was then terminated. The patient had no recall of the procedure.
Maintenance of general anesthesia using remimazolam allowed the use of a neurostimulator with minimal muscle-relaxant effects, and extubation under sedation reduced the risk of abrupt and unexpected changes in blood pressure, body movement, and coughing. Furthermore, after extubation, the patient was rendered fully awake using flumazenil to confirm the presence of recurrent laryngeal nerve palsy and active postoperative hemorrhage. In addition, the patient had no memory of the reoperation, suggesting that the anterograde amnesic effect of remimazolam had a favorable psychological outcome associated with the reoperation. We safely managed thyroid surgery using remimazolam and flumazenil.
严重上呼吸道梗阻、血肿形成和喉返神经麻痹已被报道为甲状腺手术的术后并发症。尽管瑞马唑仑可能降低这些并发症的风险,但氟马西尼与瑞马唑仑联用的疗效尚未见报道。我们介绍了使用瑞马唑仑和氟马西尼成功进行甲状腺手术麻醉管理的病例。一名72岁女性被诊断为甲状腺肿,计划在全身麻醉下行甲状腺部分切除术。我们在脑电双频指数监测下,使用神经完整性监测仪、肌电图和气管内导管,采用瑞马唑仑进行诱导和维持麻醉。手术结束时,静脉注射舒更葡糖钠后确认患者自主呼吸恢复,患者在轻度镇静下拔管。在手术室,我们静脉注射氟马西尼以确认喉返神经麻痹和术后活动性出血。患者在完全清醒状态下未出现喉返神经麻痹,但血压正常情况下发生了术后活动性出血。患者需要再次手术,并在静脉注射丙泊酚后重新插管。使用5%地氟醚维持麻醉,患者术后无任何问题并顺利拔管。随后结束麻醉。患者对手术过程无记忆。
使用瑞马唑仑维持全身麻醉可在肌肉松弛作用最小的情况下使用神经刺激器,镇静下拔管可降低血压、身体活动和咳嗽突然意外变化的风险。此外,拔管后,使用氟马西尼使患者完全清醒,以确认喉返神经麻痹和术后活动性出血的存在。此外,患者对再次手术无记忆,这表明瑞马唑仑的顺行性遗忘作用对再次手术产生了良好的心理影响。我们使用瑞马唑仑和氟马西尼安全地完成了甲状腺手术。